The Presentations

Conference Vienna 2026

In April 2026, over 140 patient advocates, clinicians, researchers, and policymakers came together in Vienna for the first ever Lung Cancer Europe Annual Conference. Three days of learning, discussion, and shared purpose, brought together under one theme: growing together, creating change.

The presentations from all three days are available to download below. Whether you were there in person and want to revisit a session, or you're exploring the programme for the first time, we hope these resources are useful. They cover some of the most pressing issues in lung cancer care and advocacy in Europe today, from AI in screening and personalised treatment, to patient partnerships in research, access to clinical trials, and the Right to be Forgotten.

Videos from the conference are currently being edited and will be available here soon.

Wednesday 22 April - Conference Opening

The conference opened with a keynote session bringing together perspectives from across the European lung cancer landscape, including voices from EU policy, clinical practice, patient advocacy, and cancer research. Sessions addressed the state of lung cancer in Europe, what Europe's Beating Cancer Plan means in practice, and how the patient voice can drive real change in care and policy.

Hugo Soares, ECHoS Project - Building National Cancer Mission Hubs: A new model for impact
Hugo Soares, ECHoS Project - Building National Cancer Mission Hubs: A new model for impact
Elisabetta Zanon, European Cancer Organisation - Europe's Beating Cancer Plan: What it means for lung cancer
Elisabetta Zanon, European Cancer Organisation - Europe's Beating Cancer Plan: What it means for lung cancer
Dr Mary Bussell, TriMar Strategies - From consensus to action: Delivering change for lung cancer in Europe
Dr Mary Bussell, TriMar Strategies - From consensus to action: Delivering change for lung cancer in Europe
Elisabetta Zanon, European Cancer Organisation - Europe's Beating Cancer Plan: What it means for lung cancer
Elisabetta Zanon, European Cancer Organisation - Europe's Beating Cancer Plan: What it means for lung cancer

Thursday 23 April - Science, Innovation and Patient Voice

Thursday brought together expert speakers across three major themes: the future of lung cancer in Europe, artificial intelligence and data in cancer care, and personalised treatment. Sessions were designed to equip patient advocates with practical knowledge on access inequalities, emerging therapies, shared decision making, and cross-border clinical trial participation.

Penilla Gunther, European Commission Cancer Mission Board - EU Cancer Mission and Europe's Beating Cancer Plan: Why care at a national level?
Penilla Gunther, European Commission Cancer Mission Board - EU Cancer Mission and Europe's Beating Cancer Plan: Why care at a national level?
Professor Marie-pierre Revel, Université Paris Cité - AI in lung cancer screening: What works, what fails, and why
Professor Marie-pierre Revel, Université Paris Cité - AI in lung cancer screening: What works, what fails, and why
Elena Petelos, University of Crete - From evidence to access: How AI in lung cancer reaches patients
Elena Petelos, University of Crete - From evidence to access: How AI in lung cancer reaches patients
Nadja Kartschmit, Medical University Vienna - Federated data and real-world evidence: What this means for advocacy and policy
Nadja Kartschmit, Medical University Vienna - Federated data and real-world evidence: What this means for advocacy and policy
Professor Jürgen Wolf, University Hospital of Cologne - Personalised lung cancer care: Current options and new treatments on the horizon
Professor Jürgen Wolf, University Hospital of Cologne - Personalised lung cancer care: Current options and new treatments on the horizon
Roxane Chen, University of Cambridge - Overview of resistance mechanisms in lung cancer
Roxane Chen, University of Cambridge - Overview of resistance mechanisms in lung cancer
Associate Professor Febe van Maldegem, Amsterdam UMC - The importance of understanding the tumour microenvironment
Associate Professor Febe van Maldegem, Amsterdam UMC - The importance of understanding the tumour microenvironment
Dr Jens Ulrich Rüffer, Deutsche Fatigue Gesellschaft - Making treatment decisions together: What should guide choices?
Dr Jens Ulrich Rüffer, Deutsche Fatigue Gesellschaft - Making treatment decisions together: What should guide choices?
Dr Ivan Pourmir, Hôpital Européen Georges-Pompidou - Considering a clinical trial abroad: A patient perspective
Dr Ivan Pourmir, Hôpital Européen Georges-Pompidou - Considering a clinical trial abroad: A patient perspective

Friday 24 April - Members’ Day

Friday was dedicated to Lung Cancer Europe member organisations, with peer learning, initiative updates, and open discussion. The afternoon included a session on advocacy and patient rights that generated significant response from members across Europe.

Kinga Wójtowicz, EDACS - The Right to be Forgotten: A practical advocacy tool for cancer survivors
Kinga Wójtowicz, EDACS - The Right to be Forgotten: A practical advocacy tool for cancer survivors

Warsaw 2027

Coming Next:

The second Lung Cancer Europe Annual Conference will take place in Warsaw in April 2027.

Planning is already underway. Sign up to the Lung Cancer Europe newsletter to stay informed.

sign up
sign up

Follow us on LinkedIn

Stay in the loop

Sign up to receive updates about the Vienna 2026 Conference, including confirmed speakers and programme news. This sign-up is for updates only and does not register you for the conference.

By signing up, you agree to receive emails from Lung Cancer Europe about this event. You can unsubscribe at any time. Read our Privacy Policy to learn how we handle your data.